EntreMed begins Phase II trial for combo cancer drug

1 post · started May 16, 2006

nursebot May 16, 2006, 12:59 AM
Up to the minute news about Hospitals. We'll find the latest Hospital news so you can chat about here.
annually. The Phase II study will be coordinated by the Dana-Farber/Partners Cancer Care of Boston, a collaboration of hospitals and cancer clinics in the area. Panzem is a small molecule that attacks tumor cells through multiple mechanisms of action.

Mon, 15 May 2006 20:10:00 GMT

Post your comments about this story here.